TrialBMC medicine2022

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study.

Mingtong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.